TS03 Inc Trust Units TSTIF

RE:Readthrough from Getinge's Quarter

[dant2]

You could be right Drrwong. The 25% YoY increase in Surgical Workflows was the single most significant change in Getinges operational performance during Q3. Jeffereies and Co probed this point (first question) during the analyst Q & A portion of the call, and Getinges CEO was rather coy but said essentially that during Q1 Getinge had developed and began implementing an new market plan for Surgical Workflows in North America and that they had begun to feel the positive effects of these new iniatives during Q3.
You may recall that RR alluded to such activities during Q1 and the related positive effects on customer installs. Of course this may not yet affect TOS Q3 shipments due to Getinge' potentially large backlog... but when questioned on this again later in the call (NA SW) Getinge' CEO stated that they expected to see continued strong results in Q4, 2018 and beyond. As you mentioned Infection Control is only part of the SW division but it seems they are getting some decent traction where it counts, and with more to come as TOS continues to differientiate the VP4 as 'the' superior sterilization solution.
One topic not discussed during the call but reported for the quarter was the revamped Stericool device aquired in late 2015. Of course it cannot compete with the VP4 in NA but apparantly it is targeted for Europe?
==========
Surgical Workflows
New Release of Stericool Low Temperature Sterilizer. During the quarter, Getinge released its latest version of the Stericool low temperature hydrogen peroxide plasma sterilizer. This release includes important new features such as the Independent Monitoring Supervisor (IMS) to support customers with real-time monitoring of critical data from independent sensors, to give users additional verification of process parameters. In addition the release contains an improved power control unit and language support for European markets.
===========
With this apparent uptick here in NA hopefully we hear something about expanding manufacturing capacity during TOS' Q3 call early next month.